Christopher Robinson/LinkedIn
Mar 6, 2026, 03:24
Christopher Robinson: The Effect of Aspirin on the Risk of Preeclampsia
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“AJOG Presents: The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first-trimester risk.”
Proceed to the video attached to the post.
Title: The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first-trimester risk
Authors: Emmanuel Bujold, Daniel L. Rolnik, Liona Poon, Argyro Syngelaki, David Wright, Kypros H. Nicolaides
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 6, 2026, 09:17Expanding Knowledge on Endometriosis Awareness Month – ESHRE
-
Mar 6, 2026, 09:05Timing Makes All The Difference in IVF! – Fertility Plus
-
Mar 6, 2026, 08:43Recombinant LH Fails to Improve Pregnancy Outcomes in IVF Study – RBMO
-
Mar 6, 2026, 02:44Geoffroy Robin Joins Webinar on Hormonal Treatment Concerns in Endometriosis – ENDHAUTS
-
Mar 5, 2026, 16:30ARCS and BFS Publish Addendum to 2023 ICSI Guidelines – ARCS
-
Mar 5, 2026, 16:21Sofiane Bendifallah: Endometriosis Diagnosis in Focus at ‘Crossed Views’ Scientific Session
-
Mar 5, 2026, 16:12Register for 35th Practical Obstetrics and Gynecology Exhibition – Practical Gynecology and Obstetrics
-
Mar 5, 2026, 07:50The Government’s Project on Perinatal Care – CNGOF
-
Mar 5, 2026, 07:25Study Explores Fertility Preservation Decisions Among Transgender Individuals – RBMO